Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-12
2005-07-12
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S355000
Reexamination Certificate
active
06916803
ABSTRACT:
The present invention relates to novel Syn isomers of racemates and optical isomers of 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids of the following formula:and their use in treating infections caused by gram-negative pathogenic bacteria.
REFERENCES:
patent: 5112968 (1992-05-01), Treuner
patent: 5250691 (1993-10-01), Straub et al.
patent: 0 204 207 (1986-12-01), None
patent: 2 218 095 (1989-11-01), None
patent: WO 98 47895 (1998-10-01), None
patent: WO 99 10324 (1999-03-01), None
Nishida, K. et al. (1999) “In vitro and in vivo activities of Syn2190, a novel beta-lactamase Inhibitor”Antimicrobial Agents and Chemotherapy43(8):1895-1900.
Fiakpui Charles
Maiti Samarendra
Micetich Ronald George
Reddy Andhe V. Narender
Salama Sameeh M.
Berch Mark L.
Pantherix, Ltd.
Saliwanchik Lloyd & Saliwanchik
LandOfFree
3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3404003